Photothermal Antibacterial Therapy of Near-Infrared II Region Laser Mediated by Gold Hollow Nanorod

The current traditional treatment for bacterial infections is to treat them with antibiotics, and the misuse of antibiotics can lead to an increase in bacterial resistance. In contrast, the development of new antibiotics is much slower than the speed of adaptation of drug-resistant bacteria, making it necessary to develop a drug that does not rely on antibiotics. Therefore, based on the advantages of photothermal therapy, NIR II-responsive gold hollow nanorods (GHNRs) were developed to overcome the limitation of bacterial drug resistance in conventional bacterial therapy. GHNRs can quickly respond to a 980 nm laser with a high photothermal conversion efficiency of 41.78%. The high temperature produced by GHNRs can effectively kill Staphylococcus aureus and Escherichia coli, providing a new strategy for the clinical treatment of bacterial infectious diseases without antibiotic dependence.